Not only low Morgana expression levels can be the driving cause of human aCML, but our work highlighted that Morgana downregulation cooperates with the BCR/ABL oncogene in the 16% of CML Ph positive (Ph+) patients. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.